Document is current
Any future updates will be listed below
-
Authors
Emwas, Abdul-Hamid
Zacharias, Helena U.
Alborghetti, Marcos Rodrigo
Gowda, G. A. Nagana
Raftery, Daniel
McKay, Ryan T.
Chang, Chung-ke
Saccenti, Edoardo
Gronwald, Wolfram
Schuchardt, Sven
Leiminger, Roland
Merzaban, Jasmeen
Madhoun, Nour Y.
Iqbal, Mazhar
Alsiary, Rawiah A.
Shivapurkar, Rupali
Pain, Arnab
Shanmugam, Dhanasekaran
Ryan, Danielle
Roy, Raja
Schirra, Horst Joachim
Morris, Vanessa
Zeri, Ana Carolina
Alahmari, Fatimah
Kaddurah-Daouk, Rima
Salek, Reza M.
LeVatte, Marcia
Berjanskii, Mark
Lee, Brian
Wishart, David S.
-
Funding
Funding for this research was provided by:
King Abdullah University of Science and Technology
- License Information
-
More Information
Article History
Received: 12 February 2025
Accepted: 4 April 2025
First Online: 10 May 2025
Declarations
:
: Dr. Kaddurah-Daouk is an inventor on a series of patents on use of metabolomics for the diagnosis and treatment of CNS diseases and holds equity in Metabolon Inc., Chymia LLC and PsyProtix.
